Synovate Healthcare licenses longitudinal oncology data from IMPAC Medical Systems
29 March 2005
MAHWAH, NEW JERSEY — SYNOVATE Healthcare, a leading healthcare market research company and provider of oncology insights, has reached agreement to license longitudinal oncology data from IMPAC Medical Systems, a leading provider of electronic medical record software for oncology communities. Under the agreement, IMPAC will provide Synovate Healthcare with de-identified patient data from electronic medical records completed by clinicians and its National Oncology DatabaseTM.
Jackie Ilacqua, Senior Vice President and Executive Director of Synovate Healthcare's Global Tandem Oncology Monitor commented:"We are very excited about the additional insights and added value that this agreement will enable us to provide our clients. It brings together the strengths of Tandem, the largest and most representative oncology physician sample available in the US, with the significant patient record numbers and longitudinal analysis available through IMPAC data."
The agreement will allow Synovate Healthcare to build on its gold standard Tandem Oncology Monitor in the US, by expanding its services to include supplements such as epidemiology models, longitudinal analysis (including treatment algorithms) and many other analyses related to treatment of cancer patients. Joe Jachinowski, President and CEO at IMPAC added: "Our partnership with Synovate Healthcare, the Global leader in oncology market analysis, is an important strategic alliance for IMPAC. It will result in significant benefits for the oncology community in terms of deeper market insights and understanding, leading to longer term benefits for cancer treatment in the US."
This move further develops Synovate Healthcare's objective to work on behalf of its oncology clients to provide them with access to information that meets all their oncology data and marketing analysis needs through a single, class leading, supplier.
Contact(s) for this press release
|
Jackie Ilacqua
Senior Vice President and Executive Director, Global Tandem Oncology Monitor |
|
|
1200 Macarthur Blvd, |
Telephone: +1 201 529 5540 |
Synovate Healthcare is the global specialist healthcare market research arm of Synovate, dedicated to delivering marketing insights to the pharmaceutical and healthcare industries. Synovate Healthcare employs over 500 healthcare market research professionals across Europe, US, Canada, Asia Pacific and Japan and offers syndicated and custom research as well as global fieldwork capabilities.
More information on Synovate Healthcare can be found at www.synovate.com/healthcare.
About Aegis Group plc
Aegis Group plc is the holding company for Carat, its media strategy, planning and buying business, and Synovate, its market research business. These two operating groups provide clients with a range of services across media communications, marketing consultancy and market research. Listed on the London Stock Exchange, Aegis is capitalised at around £1.1 billion and operates in 64 countries.
More information on Aegis Group plc can be found at www.aegisplc.com.
About IMPAC Medical Systems, Inc
IMPAC Medical Systems, Inc. is a leading provider of oncology IT solutions that streamline both clinical and business operations to help improve the process of delivering quality patient care. With systems designed for anatomic pathology, medical oncology, radiation oncology, imaging, clinical laboratory, practice management, cancer registry, and outcomes reporting IMPAC supports the entire team of healthcare professionals who contribute to the care of the cancer patient. Supporting more than 2500 installations worldwide, IMPAC provides practical solutions that deliver better overall communication, process efficiency and quality patient care. More information on IMPAC can be found at www.impac.com.